|
SHASUNPHAR Group (B) 17 Nov,15:42
428.85
22.50 (5.54%)
HOW HOT IS THIS STOCK?
Last 15 days data © Rediff.com Add to Watchlist
|
BSE
 ZoomRefreshDay
Wk
Mn
6Mn
Yr
|
2 min read
9 minutes ago
1 min read
9 minutes ago
1 min read
44 minutes ago
1 min read
55 minutes ago
| Mar ' 15 | Mar ' 14 | Mar ' 13 | Mar ' 12 | Mar ' 11 | |
|---|---|---|---|---|---|
| Sales | 1,078.40 | 934.72 | 782.76 | 735.91 | 567.85 |
| Operating profit | 112.90 | 89.45 | 68.13 | 51.52 | 39.16 |
| Interest | 45.61 | 35.62 | 26.49 | 30.48 | 21.50 |
| Gross profit | 81.21 | 66.10 | 55.30 | 62.00 | 32.11 |
| EPS (Rs) | 6.87 | 6.22 | 4.64 | 9.63 | 1.01 |
2 min read
9 minutes ago
1 min read
9 minutes ago
Q: What is the current share price of Shasun Pharmaceuticals Ltd.[Merged]?
A: The current share price of Shasun Pharmaceuticals Ltd.[Merged] is ₹ 428.85 (for BSE as on 17 Nov,15:42). The 52-week range is ₹ 432.05 - 209.80. Prices are updated based on live market data.
Q: What is the market capitalization of Shasun Pharmaceuticals Ltd.[Merged]?
A: Shasun Pharmaceuticals Ltd.[Merged] has a market capitalization of ₹ 2,884.02 Cr, making it a company.
Q: What is the PE ratio of Shasun Pharmaceuticals Ltd.[Merged]?
A: The Price-to-Earnings (PE) ratio of Shasun Pharmaceuticals Ltd.[Merged] is , indicating its valuation relative to earnings.
Q: Is Shasun Pharmaceuticals Ltd.[Merged] a good investment?
A: Shasun Pharmaceuticals Ltd.[Merged] is considered based on its financial performance, sector outlook, and market conditions. Investors should evaluate fundamentals and consult financial advisors before investing.
Q: Does Shasun Pharmaceuticals Ltd.[Merged] pay dividends?
A: Yes. Shasun Pharmaceuticals Ltd.[Merged] pay dividends. The latest dividend yield is 50%.
Q: What are the latest financial results of Shasun Pharmaceuticals Ltd.[Merged]?
A: Shasun Pharmaceuticals Ltd.[Merged] has reported its latest annual results with revenue of ₹ 1,078.40 and net profit/loss of ₹ 41.34.
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
